ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ORCL Oracle Corp

114.68
0.93 (0.82%)
After Hours
Last Updated: 21:37:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Oracle Corp NYSE:ORCL NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.93 0.82% 114.68 116.76 113.65 113.97 5,581,809 21:37:00

Everest Group PEAK Matrix™ Assessment for Life Sciences Clinical Trial Products Names Oracle Health Sciences as a Top Leade...

14/11/2017 1:00pm

PR Newswire (US)


Oracle (NYSE:ORCL)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Oracle Charts.

REDWOOD SHORES, Calif., Nov. 14, 2017 /PRNewswire/ -- Oracle Health Sciences today announced that it has been identified as a Leader in the top quartile in Everest Group's PEAK Matrix™ Assessment of Life Sciences Clinical Trial Products 2017.

Oracle Logo

Oracle Health Sciences received superior marks in "clinical trials value chain coverage" which included pre-clinical, clinical trials, pharmacovigilance and regulatory affairs.  

"We believe our being named a leader and in the top position is further validation of Oracle's continued momentum in the eClinical space," said Steve Rosenberg, general manager, Oracle Health Sciences. "We realized some time ago that the way technology was supporting clinical research had to change.  The collections of point solutions you see on the market today are not serving the industry's needs.  Our response to this problem is Clinical One.  Our vision, resources and technology are designed to carry our customers into the future with a single cloud-based eClinical platform that unifies clinical teams, processes and data in a profound new way."

Unlike other reports and analyses that rank solution providers solely based on revenue, Everest Group assesses companies based on market impact (market adoption, value delivered and portfolio mix) as well as vision and capability (vision and strategy, functionality, flexibility and ease of deployment, engagement and commercial model and support) to evaluate marketplace success.

"After evaluating Oracle's vision and capability as well as market impact for their Clinical One Platform, which is approaching clinical technology in a new and innovative manner, we placed them as a Leader. In addition to their market penetration, Oracle's breadth and depth of capabilities represent what we consider to be a leading solution in the eClinical space," said Nitish Mittal, Practice Director, Everest Group.

Additional Resources 
Download the Everest Group PEAK Matrix Summary Report 
Learn more about Oracle Health Sciences Clinical One eClinical Platform

About Oracle
The Oracle Cloud offers complete SaaS application suites for ERP, HCM and CX, plus best-in-class database Platform as a Service (PaaS) and Infrastructure as a Service (IaaS) from data centers throughout the Americas, Europe and Asia. For more information about Oracle (NYSE:ORCL), please visit us at www.oracle.com.

Trademarks
Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.

 

View original content with multimedia:http://www.prnewswire.com/news-releases/everest-group-peak-matrix-assessment-for-life-sciences-clinical-trial-products-names-oracle-health-sciences-as-a-top-leader-300555202.html

SOURCE Oracle

Copyright 2017 PR Newswire

1 Year Oracle Chart

1 Year Oracle Chart

1 Month Oracle Chart

1 Month Oracle Chart

Your Recent History

Delayed Upgrade Clock